Neurophysiologic abnormalities in children with Charcot-Marie-Tooth disease type 1A

Eppie M Yiu1, Joshua Burns, Monique M Ryan

  • 1Children's Neuroscience Centre, Royal Children's Hospital, Melbourne, Victoria, Australia.

Insights

Neurophysiologic abnormalities are present in all children with Charcot-Marie-Tooth disease type 1A (CMT1A) from age two. Motor nerve conduction slowing progresses until age six, then stabilizes, with reduced muscle action potential amplitudes noted early.

Area of Science:

  • Neurology
  • Pediatrics
  • Genetics

Background:

  • Charcot-Marie-Tooth disease type 1A (CMT1A) is a common inherited neuropathy.
  • Limited large-scale studies detail pediatric neurophysiologic features of CMT1A.

Purpose of the Study:

  • To characterize the neurophysiologic findings in a large cohort of children with CMT1A.
  • To describe the age-related progression of neurophysiologic abnormalities in pediatric CMT1A.

Main Methods:

  • Median motor and sensory nerve conduction studies were performed on 80 children aged 2-16 years with CMT1A.
  • Analysis focused on nerve conduction velocity, distal motor latency, and compound muscle action potential (CMAP) amplitude.

Main Results:

  • All children exhibited neurophysiologic abnormalities.
  • Median motor nerve conduction velocity was <33 m/s, slowing significantly in older children (7-16 years).
  • Prolonged distal motor latencies and reduced CMAP amplitudes were observed from an early age, with attenuated age-related increases.

Conclusions:

  • Neurophysiologic abnormalities are universal in pediatric CMT1A, detectable from age two.
  • Motor conduction slowing progresses through the first six years of life.
  • Reduced CMAP amplitudes and attenuated age-related increases are key findings in childhood CMT1A.

Related Concept Videos

Alterations in Muscle Tone lll01:11

Alterations in Muscle Tone lll

Rigidity and myotonia are distinct abnormalities of muscle tone that affect resistance and relaxation during movement. Although both involve altered muscle contraction, they arise from different neurological and muscular mechanisms.CharacteristicsRigidity is characterized by uniform resistance to passive movement across the entire range, independent of speed, affecting flexors and extensors equally. It may appear as lead-pipe rigidity (smooth, constant resistance) or cogwheel rigidity...
Alterations in Muscle Tone ll01:12

Alterations in Muscle Tone ll

Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Huntington Disease l: Introduction01:21

Huntington Disease l: Introduction

Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...